美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BillionToOne, Inc.

85.95

-2.7800-3.13%

盘后：86.490.5400+0.63%16:21 EST

成交量：31.93万

成交额：2,718.91万

市值：39.02亿

市盈率：-80.03

高：88.04

开：85.91

低：82.00

收：88.73

52周最高：138.70

52周最低：80.51

股本：4,540.30万

流通股本：384.60万

量比：0.93

换手率：8.30%

股息：- -

股息率：- -

每股收益(TTM):-1.0740

每股收益(LYR):-4.1240

净资产收益率：--

总资产收益率：--

市净率：-16.29

市盈率(LYR):-20.84

数据加载中...

总览公司新闻资讯公告

Billiontoone, Inc.盘中异动股价大跌5.01%

Billiontoone与Epic达成合作推动产前及肿瘤检测在医疗系统广泛覆盖

Billiontoone, Inc.盘中异动下午盘股价大跌5.14%

Billiontoone宣布选用Northstar Select®作为国立癌症研究中心东医院Lc-Scrum-TRY临床研究新型液体活检检测方案

BillionToOne超灵敏液体活检技术为日本耐药非小细胞肺癌患者拓宽精准医疗通路

Billiontoone, Inc.盘中异动早盘快速拉升5.29%报97.40美元

分析师看好 BillionToOne 在产前和癌症检测领域的增长，为其赢得了乐观报导

美国研究综述-联合银行、雪佛龙、Paychex

美国研究综述-联合银行、雪佛龙、Paychex

Billiontoone, Inc.跌3.62% 股价跌破100美元大关

BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元

异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期

异动解读 | BillionToOne上市首日，股价盘中大涨66.67%

BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33

重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元

BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股

分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元每股定价49至55美元

BillionToOne 在美国首次公开募股的目标估值超过 20 亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BLLN/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":85.95,"timestamp":1768942800000,"preClose":88.73,"halted":0,"volume":319275,"hourTrading":{"tag":"盘后","latestPrice":86.49,"preClose":85.95,"latestTime":"16:21 EST","volume":850,"amount":73072.1081,"timestamp":1768944061280,"change":0.54,"changeRate":0.006283,"amplitude":0.014892},"delay":0,"changeRate":-0.031331004169953804,"floatShares":3846000,"shares":45403000,"eps":-1.073956,"marketStatus":"盘后交易","change":-2.78,"latestTime":"01-20 17:22:21 EST","open":85.91,"high":88.035,"low":82,"amount":27189085.0443,"amplitude":0.068015,"askPrice":89.5,"askSize":30,"bidPrice":83.1,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-1.073956,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768957200000},"marketStatusCode":4,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":88.73,"preHourTrading":{"tag":"盘前","latestPrice":88.45,"preClose":88.73,"latestTime":"09:05 EST","volume":8,"amount":707.2948,"timestamp":1768917953483,"change":-0.28,"changeRate":-0.003156,"amplitude":0.005475},"postHourTrading":{"tag":"盘后","latestPrice":86.49,"preClose":85.95,"latestTime":"16:21 EST","volume":850,"amount":73072.1081,"timestamp":1768944061280,"change":0.54,"changeRate":0.006283,"amplitude":0.014892},"volumeRatio":0.928791},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","floatShares":3846000,"roa":"--","roe":"--","lyrEps":-4.124007,"volumeRatio":0.928791,"shares":45403000,"dividePrice":0,"high":88.035,"amplitude":0.068015,"preClose":88.73,"low":82,"week52Low":80.51,"pbRate":"-16.29","psRate":"15.36","week52High":138.7,"institutionHeld":0,"latestPrice":85.95,"committee":0.142857,"eps":-1.073956,"divideRate":0,"volume":319275,"delay":0,"ttmEps":-1.073956,"open":85.91,"prevYearClose":81.84,"prevWeekClose":88.73,"prevMonthClose":81.84,"prevQuarterClose":81.84,"fiveDayClose":99.15,"twentyDayClose":95.5,"sixtyDayClose":60},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1767934800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLLN","date":"2026-01-16","current":-80.031212,"percent":0.25,"low":-448.462026,"twenty":-392.928663,"median":-348.806737,"eighty":-150.668895,"high":-87.827147,"avg":-276.983775,"sd":118.008866,"marketCap":4335216947},"quantilePoints":[{"date":"2025-11-07","current":-159.132389,"twenty":-144.871341,"median":-123.479768,"eighty":-102.088195,"marketCap":4871838088},{"date":"2025-11-14","current":-130.808752,"twenty":-151.11734,"median":-148.702746,"eighty":-133.870451,"marketCap":4004709939},{"date":"2025-11-21","current":-139.763053,"twenty":-149.199396,"median":-143.65591,"eighty":-132.43601,"marketCap":4278845862},{"date":"2025-11-28","current":-193.061188,"twenty":-160.680767,"median":-147.409996,"eighty":-136.31572,"marketCap":5910568267},{"date":"2025-12-05","current":-154.265054,"twenty":-170.43011,"median":-151.565786,"eighty":-139.763053,"marketCap":4722824636},{"date":"2025-12-12","current":-402.174044,"twenty":-192.645939,"median":-154.739624,"eighty":-142.260908,"marketCap":4459707974},{"date":"2025-12-19","current":-394.166884,"twenty":-381.825952,"median":-160.680767,"eighty":-145.050911,"marketCap":4370916580},{"date":"2025-12-26","current":-356.359883,"twenty":-394.819014,"median":-167.642009,"eighty":-145.90398,"marketCap":3951674738},{"date":"2026-01-02","current":-337.786574,"twenty":-386.762325,"median":-177.845273,"eighty":-147.668546,"marketCap":3745715318},{"date":"2026-01-09","current":-361.519135,"twenty":-391.80601,"median":-193.061188,"eighty":-149.075233,"marketCap":4008885688},{"date":"2026-01-16","current":-390.947511,"twenty":-392.928663,"median":-348.806737,"eighty":-150.668895,"marketCap":4335216947}],"updateTime":1768944010025},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLLN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604085949","title":"Billiontoone, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604085949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604085949?lang=zh_cn&edition=fundamental","pubTime":"2026-01-17 03:25","pubTimestamp":1768591522,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日03时25分，Billiontoone, Inc.股票出现波动，股价快速下跌5.01%。Billiontoone, Inc.股票所在的生命科学行业中，整体跌幅为0.67%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global、Personalis, Inc.涨幅较大，Ispecimen Inc.、Personalis, Inc.、Biodesix, Inc.较为活跃，换手率分别为15.59%、3.08%、2.77%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global Limited C/Wts 18/05/2027 、Ispecimen Inc.，振幅分别为84.00%、19.87%、14.29%。Billiontoone, Inc.公司简介：BillionToOne Inc是一家精密诊断公司，其专利的定量计数模板平台革新了分子检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117032522953d1d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117032522953d1d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"1169829335","title":"Billiontoone与Epic达成合作 推动产前及肿瘤检测在医疗系统广泛覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=1169829335","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169829335?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 22:01","pubTimestamp":1768485693,"startTime":"0","endTime":"0","summary":"基因检测公司Billiontoone近日宣布与医疗信息化巨头Epic建立战略合作关系，双方将共同推进产前筛查与肿瘤检测技术在临床医疗场景的规模化应用。此次合作旨在通过整合Billiontoone的尖端分子诊断技术与Epic的电子健康记录系统，构建无缝衔接的检测数据流，助力医疗机构实现更高效、精准的疾病风险评估与管理。业内人士分析指出，该合作有望突破传统检测服务的时空限制，为孕产妇群体和肿瘤患者提供贯穿诊疗全周期的动态监测解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601352370","title":"Billiontoone, Inc.盘中异动 下午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601352370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601352370?lang=zh_cn&edition=fundamental","pubTime":"2026-01-08 03:09","pubTimestamp":1767812968,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日03时09分，Billiontoone, Inc.股票出现异动，股价大幅跳水5.14%。Billiontoone, Inc.股票所在的生命科学行业中，整体跌幅为0.06%。其相关个股中，燃石医学、Genedx Holdings Corp C/Wts 22/07/2026 、Fulgent Genetics, Inc.涨幅较大，Mainz Biomed N.V.、Ispecimen Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为5.82%、2.55%、2.28%，振幅较大的相关个股有Mainz Biomed N.V.、Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.，振幅分别为20.00%、19.49%、12.40%。Billiontoone, Inc.公司简介：BillionToOne Inc是一家精密诊断公司，其专利的定量计数模板平台革新了分子检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108030928953c2b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108030928953c2b3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"1197071966","title":"Billiontoone宣布选用Northstar Select®作为国立癌症研究中心东医院Lc-Scrum-TRY临床研究新型液体活检检测方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197071966","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197071966?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 22:09","pubTimestamp":1767708555,"startTime":"0","endTime":"0","summary":"精准医疗企业Billiontoone近日宣布，其创新液体活检产品Northstar Select已被正式选定为国立癌症研究中心东医院开展的Lc-Scrum-TRY临床研究项目的新型检测工具。此次合作将依托Northstar Select的高灵敏度特性，对参与Lc-Scrum-TRY研究的肺癌患者进行循环肿瘤DNA监测。国立癌症研究中心东医院作为日本顶尖肿瘤研究机构，其主导的Lc-Scrum-TRY项目旨在建立肺癌治疗响应评估新范式。引入Billiontoone的液体活检技术，有望突破传统组织活检的时空局限性，实现治疗过程中肿瘤基因演变的连续追踪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"1155397923","title":"BillionToOne超灵敏液体活检技术 为日本耐药非小细胞肺癌患者拓宽精准医疗通路","url":"https://stock-news.laohu8.com/highlight/detail?id=1155397923","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155397923?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 22:07","pubTimestamp":1767708457,"startTime":"0","endTime":"0","summary":"BillionToOne公司推出的超灵敏液体活检技术，正在日本市场显著提升耐药性非小细胞肺癌患者获得精准医疗的机会。这项创新检测方法通过高灵敏度分析血液中的循环肿瘤DNA，能够精准识别对传统治疗方案产生抵抗的肺癌患者的特定基因突变，从而为临床医生制定个性化治疗策略提供关键依据。\n目前，该技术已开始在日本多家医疗机构推广应用，有望改变耐药非小细胞肺癌患者的治疗格局。与传统组织活检相比，液体活检具有创伤小、可重复性强等优势，特别适合需要长期监测治疗反应的患者群体。随着精准医疗理念的深入，这项技术将为更多日本肺癌患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2592166272","title":"Billiontoone, Inc.盘中异动 早盘快速拉升5.29%报97.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592166272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592166272?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 22:50","pubTimestamp":1766069441,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时50分，Billiontoone, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报97.40美元/股，成交量9961股，换手率0.02%，振幅4.51%。Billiontoone, Inc.股票所在的生命科学行业中，整体涨幅为0.82%。Billiontoone, Inc.公司简介：BillionToOne Inc是一家精密诊断公司，其专利的定量计数模板平台革新了分子检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218225041a6b31a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218225041a6b31a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2588372436","title":"分析师看好 BillionToOne 在产前和癌症检测领域的增长，为其赢得了乐观报导","url":"https://stock-news.laohu8.com/highlight/detail?id=2588372436","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588372436?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 19:41","pubTimestamp":1764589272,"startTime":"0","endTime":"0","summary":"截至上周五，BillionToOne 的股价为 130.18 美元，比其 60 美元的首次公开发行价上涨了约 117%，对这家总部位于门洛帕克的公司的估值为 59.1 亿美元。Piper Sandler 分析师给予该公司 \"增持 \"评级，目标价为 150 美元，认为 BillionToOne 的肿瘤液体活检产品 \"改变了 \"治疗选择和监测的 \"游戏规则\"。它指出，虽然 BillionToOne 的技术很强大，但在癌症检测方面取得成功还需要时间。BillionToOne成立于2016年，利用专有的单分子下一代测序技术开发无创产前和肿瘤血液测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4T3X70UN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CAI","BK4139","BLLN","BK4104"],"gpt_icon":0},{"id":"2588744948","title":"美国研究综述-联合银行、雪佛龙、Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2588744948","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588744948?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 15:27","pubTimestamp":1764574063,"startTime":"0","endTime":"0","summary":"美国研究综述-联合银行、雪佛龙、Paychex路透12月1日 - 华尔街证券分析师周一调整了对 Bankunited、雪佛龙和 Paychex 等几家美国上市公司的评级和目标价。要闻 * 美国联合银行BKU.N：杰富瑞将其评级从 \"持有 \"上调至 \"买入\"，目标价从 42 美元上调至 55 美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4T3X70HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EGBN","LU1633808545.USD","RGEN","BETA","BK4130","000338","RYAN","LU0820562030.AUD","SGXZ99366536.SGD","WAL","WWD","LU0077335932.USD","IQV","FIZN","WBS","PB","LU0557290698.USD","LU0342679015.USD","CVX","LU2240825500.USD","CRWD","LU1939255532.USD","SGXZ57979304.SGD","XOM","EWBC","OKTA","GSHD","BK0005","ULTA","WM","BKU","MNST","SNV","PAYX","LU1983299246.USD","PNFP","LU1366333091.USD","TCBI","TMO","PSIX","BLLN","LU0234572021.USD","FHN","WTFC","ZION","FCNCA","MTB","LU0472753341.HKD","DHR","BK0175"],"gpt_icon":0},{"id":"2588074491","title":"美国研究综述-联合银行、雪佛龙、Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074491","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588074491?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 15:27","pubTimestamp":1764574063,"startTime":"0","endTime":"0","summary":"美国研究综述-联合银行、雪佛龙、Paychex路透12月1日 - 华尔街证券分析师周一调整了对 Bankunited、雪佛龙和 Paychex 等几家美国上市公司的评级和目标价。要闻 * 美国联合银行BKU.N：杰富瑞将其评级从 \"持有 \"上调至 \"买入\"，目标价从 42 美元上调至 55 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4S3X70HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","PAYX","LU0170899867.USD","ZION","FHN","LU2468319806.SGD","OKTA","WM","EGBN","RGEN","CVX","LU0256863811.USD","WWD","TMO","BK4106","TCBI","IE00B7SZL793.SGD","MTB","BETA","GSHD","WTFC","GB00BDT5M118.USD","000338","LU1670628061.USD","BK4201","RYAN","ULTA","WAL","IQV","LU0417517546.SGD","WBS","FCNCA","FIZN","BKU","EWBC","IE00BFTCPJ56.SGD","PB","LU0882574055.USD","BLLN","SNV","MNST","SG9999004303.SGD","LU0072461881.USD","PSIX","BK4535","BK0175","DHR","CRWD","PNFP","XOM"],"gpt_icon":0},{"id":"2583753853","title":"Billiontoone, Inc.跌3.62% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2583753853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583753853?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 00:39","pubTimestamp":1762965574,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日00时39分，Billiontoone, Inc.股票出现异动，股价急速跳水3.62%。Billiontoone, Inc.股票所在的生命科学行业中，整体涨幅为0.58%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Check-Cap Ltd.、Endra Life Sciences Inc.涨幅较大，Check-Cap Ltd.、Mainz Biomed N.V.、Endra Life Sciences Inc.较为活跃，换手率分别为2.10%、1.77%、1.72%，振幅较大的相关个股有Check-Cap Ltd.、Endra Life Sciences Inc.、Mainz Biomed N.V.，振幅分别为15.42%、11.85%、10.38%。Billiontoone, Inc.公司简介：BillionToOne Inc是一家精密诊断公司，其专利的定量计数模板平台革新了分子检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111300393495004a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111300393495004a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLLN"],"gpt_icon":0},{"id":"2581491700","title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581491700","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581491700?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 06:00","pubTimestamp":1762466400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物分子诊断公司BillionToOne周四正式登陆纳斯达克，开盘股价暴涨，截至收盘，该股涨幅为81.57%，市值迅速升至近48亿美元，成为政府停摆背景下逆势上市的亮眼新股。BillionToOne此次发行价为60美元，开盘即跳涨至100美元，盘中最高逼近123.45美元。BillionToOne 目前位于加州门洛帕克，专注开发基于单分子测序技术的无创产前检测及肿瘤血液检测。在政府停摆持续、SEC审批程序受限的情况下，BillionToOne的成功上市被视为IPO市场回暖的重要信号。","market":"sh","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366325.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLLN","BK1147","BK4007"],"gpt_icon":0},{"id":"1191654904","title":"异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191654904?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne, Inc.今日在纳斯达克首次公开交易，盘中大涨66.67%，引起市场广泛关注。据悉，BillionToOne的股票开盘价为每股100美元，较60美元的发行价大幅上涨66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价高于预期区间。总部位于加利福尼亚州门洛帕克市的BillionToOne主要开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。BillionToOne的强劲debut表明投资者对其业务前景及生物科技行业整体保持乐观态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1131573131","title":"异动解读 | BillionToOne上市首日，股价盘中大涨66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131573131?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne今日在纳斯达克证券交易所首次亮相，股价表现亮眼，盘中大涨66.67%，引发市场广泛关注。据悉，BillionToOne的IPO发行价为每股60美元，而开盘价高达100美元，较发行价溢价66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价明显高于预期区间。此次成功上市不仅为BillionToOne带来了可观的融资，也反映了投资者对其业务前景的看好。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"2581097986","title":"BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33","url":"https://stock-news.laohu8.com/highlight/detail?id=2581097986","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581097986?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 23:33","pubTimestamp":1762443192,"startTime":"0","endTime":"0","summary":"11月6日 - ** 分子诊断公司BillionToOne的BLLN.O股票在纳斯达克首次上市时的开盘价将比发行价高出33.3%。** BLLN 开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。** 在截至 6 月 30 日的六个月中，BLLN 的收入激增 82%，达到 1.255 亿美元，净亏损缩小至 420 万美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4S3WI1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","PIPR","BLLN"],"gpt_icon":0},{"id":"2581036418","title":"重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581036418","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581036418?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 12:09","pubTimestamp":1762402178,"startTime":"0","endTime":"0","summary":"更新版 1-重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元在第6段和第8-10段增加了细节和背景介绍。路透11月6日 - 分子诊断公司BillionToOne BLLN.O周三在美国首次公开募股中募集了2.731亿美元，股票定价高于市场范围。BillionToOne 是一家分子诊断公司，利用其单分子测序技术开发无创产前检查和肿瘤血液检查。BillionToOne 将在纳斯达克上市，股票代码为 \"BLLN\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4T3WI0CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","PIPR","BK4127"],"gpt_icon":0},{"id":"1147084798","title":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147084798","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147084798?lang=zh_cn&edition=fundamental","pubTime":"2025-10-29 18:02","pubTimestamp":1761732155,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2576583836","title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576583836","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576583836?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 15:38","pubTimestamp":1760945928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，分子诊断公司BillionToOne公布了其首次公开募股的条款。按照拟议价格区间的中点计算，BillionToOne 的完全稀释后市值将达到 27 亿美元。2019 年，该公司推出了其首款产前产品 UNITY，这是首个利用游离 DNA 进行隐性遗传病胎儿风险评估的无创产前检测，无需父亲样本或侵入性操作。BillionToOne 成立于 2016 年，专注于产前筛查和癌症治疗监测领域，其核心Quantitative Counting Templates技术能以单碱基对精度检测DNA分子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLLN"],"gpt_icon":0},{"id":"2576062746","title":"BillionToOne 在美国首次公开募股的目标估值超过 20 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576062746","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576062746?lang=zh_cn&edition=fundamental","pubTime":"2025-10-18 06:01","pubTimestamp":1760738513,"startTime":"0","endTime":"0","summary":"路透社10月17日 - 分子诊断公司BillionToOne BLLN.O周五表示，该公司在美国首次公开募股的目标估值高达24.2亿美元。此次发行正值美国首次公开募股活动反弹之际，扭转了今年早些时候因贸易政策不确定性抑制了IPO势头而出现的放缓趋势。BillionToOne 公司开发分子诊断测试，包括无创产前筛查和液体活检。该公司于本月早些时候提交了首次公开募股申请 ，并报告称 2025 年上半年的营收为 1.255 亿美元，而去年同期为 6900 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL3S3VY1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}